Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Reexamination Certificate
2006-01-24
2006-01-24
Chan, Christina (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
C424S135100, C435S810000, C530S387100, C530S387300, C530S388200, C530S388700, C530S391300, C530S391700
Reexamination Certificate
active
06989144
ABSTRACT:
The invention provides isolated nucleic acid molecules and polypeptide molecules that encode glycoprotein V1, a platelet membrane glycoprotein that is involved platelet-collagen interactions. The invention also provides antisense nucleic acid molecules, expression vectors containing the nucleic acid molecules of the invention, host cells into which the exposure vectors have been introduced, and non-human transgenic animals in which a nucleic acid molecule of the invention has been introduced or disrupted. The invention still further provides isolated polypeptides, fusion polypeptides, antigenic peptides and antibodies. Diagnostic, screening and therapeutic methods utilizing compositions of the invention are also provided.
REFERENCES:
patent: 5272057 (1993-12-01), Smulson et al.
patent: 5459039 (1995-10-01), Modrich et al.
patent: 5854005 (1998-12-01), Coller
patent: 5976532 (1999-11-01), Coller et al.
patent: WO 95/11259 (1995-04-01), None
patent: WO 98/32845 (1998-07-01), None
patent: WO 99/11662 (1999-03-01), None
patent: WO 00/68377 (2000-11-01), None
Janeway et al Immunobiology 4th Edition, Garland Press London, 1999.
Adams MD et al., “Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence”, Nature. Sep. 28, 1995;377(6547 Suppl):3-174.
Altschul SF et al., “Basic local alignment search tool”, J Mol Biol. Oct. 5, 1990;215(3):403-10.
Altschul SF et al., “Gapped BLAST and PSI-BLAST: a new generation of protein database search programs”, Nucleic Acids Res. Sep. 1, 1997;25(17):3389-402.
Arai M et al., “Platelets with 10% of the normal amount of glycoprotein VI have an impaired response to collagen that results in a mild bleeding tendency”, Br J Haematol. Jan. 1995;89(1):124-30.
Asselin J et al., “Monomeric (glycine-proline-hydroxyproline)10 repeat sequence is a partial agonist of the platelet collagen receptor glycoprotein VI”, Biochem J. Apr. 15, 1999;339 (Pt 2):413-8.
Barany F., “Genetic disease detection and DNA amplification using cloned thermostable ligase”, Proc Natl Acad Sci U S A. Jan. 1, 1991;88(1):189-93.
Barnes MJ et al., “The collagen-platelet interaction”, Curr Opin Hematol. Sep. 1998;5(5):314-20.
Briddon SJ and Watson SP, “Evidence for the involvement of p59fyn and p53/56lyn in collagen receptor signalling in human platelets”, Biochem J. Feb. 15, 1999;338 (Pt 1):203-9.
Carlsson LE et al., “Heparin-induced thrombocytopenia: new insights into the impact of the FcgRlla-R-H131 polymorphism”, Blood, Sep. 1, 1998;92(5):1526-31.
Chiang TM and Kang AH, “Isolation and purification of collagen alpha 1(I) receptor from human platelet membrane”, J Biol Chem. Jul. 10, 1982;257(13):7581-6.
Chiang TM et al., “Cloning, characterization, and functional studies of a nonintegrin platelet receptor for type I collagen”, J Clin Invest. Aug. 1997; 100(3):514-521.
Clemetson KJ, “Platelet activation: signal transduction via membrane receptors”, Thromb Haemost. Jul. 1995;74(1):111-6.
Clemetson JM et al., “The Platelet Collagen Receptor Glycoprotein VI Is a Member of the Immunoglobulin Superfamily Closely Related to FcalphaR and the Natural Killer Receptors”, J Biol Chem. Oct. 8, 1999;274(41):29019-29024.
Clemetson KJ et al., “Characterization of the platelet membrane glycoprotein abnormalities in Bernard-Soulier syndrome and comparison with normal by surface-labeling techniques and high-resolution two-dimensional gel electrophoresis”, J Clin Invest. Aug. 1982;70(2):304-11.
Coller et al., 1985, “A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex”, J Clin Invest. 76(1):101-8.
Cotton RG, “Current methods of mutation detection”, Mutat Res. Jan. 1993;285(1):125-44.
Cotton RG et al., “Reactivity of cytosine and thymine in single-base-pair mismatches with hydroxylamine and osmium tetroxide and its application to the study of mutations”, Proc Natl Acad Sci U S A. Jun. 1988;85(12)4397-401.
Cronin MT et al., “Cystic fibrosis mutation detection by hybridization to light-generated DNA probe arrays”, Hum Mutat. 1996;7(3):244-55.
Ezumi et al., 2000, “Molecular cloning, genomic structure, chromosomal localization, and alternative splice forms of the platelet collagen receptor glycoprotein VI”, Biochem Biophys Res Commun 277(1): 27-36.
Ezumi Y et al., “Physical and functional association of the Src family kinases Fyn and Lyn with the collagen receptor glycoprotein VI-Fc receptor gamma chain complex on human platelets”, J Exp Med. Jul. 20, 1998;188(2):267-76.
Fan et al., 1987, “Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors” Nature. 389(6646):96-100.
Gibbins JM et al., “Glycoprotein VI is the collagen receptor in platelets which underlies tyrosine phosphorylation of the Fc receptor gamma-chain”, FEBS Lett. Aug. 18, 1997;413(2):255-9.
Gibbins JM et al., “The p85 subunit of phosphatidylinositol 3-kinase associates with the Fc receptor gamma-chain and linker for activitor of T cells (LAT) in platelets stimulated by collagen and convulxin”, J Biol Chem. Dec. 18, 1998;273(51):34437-43.
Gibbs RA et al., “Detection of single DNA base differences by competitive oligonucleotide priming”, Nucleic Acids Res. Apr. 11, 1989;17(7):2437-48.
Handa M et al., “Platelet unresponsiveness to collagen: involvement of glycoprotein Ia-IIa (alpha 2 beta 1 integrin) deficiency associated with a myeloproliferative disorder”, Thromb Haemost. Mar. 1995;73(3):521-8.
Hayashi K., “PCR-SSCP: a method for detection of mutations”, Genet Anal Tech Appl. Jun. 1992;9(3):73-9.
Heemskerk JW et al., “Function of glycoprotein VI and integrin alpha2beta1 in the procoagulant response of single, collagen-adherent platelets”, Thromb Haemost. May 1999;81(5):782-92.
Hsu IC et al., “Detection of DNA point mutations with DNA mismatch repair enzymes”, Carcinogenesis. Aug. 1994;15(8):1657-62.
Ichinohe T et al., “Collagen-stimulated activation of Syk but not c-Src is severely compromised in human platelets lacking membrane glycoprotein VI”, J Biol Chem. Jan. 3, 1997;272(1):63-8.
Ichinohe T et al., “Cyclic AMP-insensitive activation of c-Src and Syk protein-tyrosine kinases through platelet membrane glycoprotein VI”, J Biol Chem. Nov. 24, 1995;270(47):28029-36.
Inoue K et al., “Signal transduction pathways mediated by glycoprotein Ia/IIa in human platelets: comparison with those of glycoprotein VI”, Biochem Biophys Res Commun. Mar. 5, 1999;256(1):114-20.
Ishibashi T, Sugiyama T, Ichinohe T, Takayama H, Okuma M. Purification of p62, a putative platelet collagen receptor, and its functional significance in collagen-induced platelet aggregation. XIVth Congress of the International Society on Thrombosis and Haemostasis, New York. Thrombosis and Haemostasis. Jul. 1993; Abstract No. 1638.
Ishibashi T, Ichinohe T, Sugiyama T, Takayama H, Titani K, Okuma M. Functional significance of platelet membrane glycoprotein p62 (GP VI), a putative collagen receptor. Int J Haematol. Aug. 1995;62(2):107-15.
Jandrot-Perrus et al., 2000, “Cloning, characterization, and functional studies of human and mouse glycoprotein VI: a platelet-specific collagen receptor from the immunoglobulin superfamily”, Blood 96(5): 1798-1807.
Jandrot-Perrus M et al., “Adhesion and activation of human platelets induced by convulxin involve glycoprotein VI and integrin alpha2beta1”, J Biol Chem. Oct. 24, 1997;272(43):27035-41.
Karlin S, and Altschul SF, “Methods for assessing the statistical significance of molecular sequence features by using general scoring schemes”, Proc Natl Acad Sci U S A. Mar. 1990;87(6):2
Busfield Samatha J.
Gill Davinder Singh
Jandrot-Perrus Martine
Kingsbury Gillian
Qian Ming Diana
Chan Christina
Huynh Phuong
Millennium Pharmaceuticals Inc.
Millennium Pharmaceuticals Inc.
LandOfFree
Glycoprotein VI antibodies and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glycoprotein VI antibodies and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glycoprotein VI antibodies and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3590989